Alcohol Related Disorders Clinical Trial
Official title:
Hepatic Function Following Five Days of Therapeutic Dosing of Acetaminophen in Alcoholics
The study objective was to determine if liver injury develops in alcoholic patients during or following 5 days of therapeutic acetaminophen dosing. Volunteers were recruited from two community detoxification centers to take either acetaminophen (4g/day) or placebo for 5 consecutive days. All subjects were monitored an additional two days following the dosing period. The primary measures were aminotransferase measures taken at baseline and Days 2, 4, 6 and 7. We hypothesized that there would be no difference in aminotransferase means between the groups at any study period.
n/a
Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator)
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01544218 -
Validating NIAAA Screen Guide in YCMC
|
N/A | |
| Withdrawn |
NCT01539954 -
Computerized Alcohol Screening for Children and Adolescents
|
N/A | |
| Active, not recruiting |
NCT01655615 -
Does Delaying Adolescent Substance Use Lead to Improved Cognitive Function and Reduce Risk for Addiction?
|
N/A | |
| Completed |
NCT00202514 -
Placebo Controlled Trial of Depakote ER in Alcohol Dependent Patients With Mood and/or Anxiety Symptoms
|
Phase 2/Phase 3 | |
| Completed |
NCT00132262 -
Brief Intervention to Reduce Injury in Minorities
|
N/A | |
| Completed |
NCT02407340 -
Laboratory Studies on Oxytocin for Treatment of Alcohol Use Disorder
|
Phase 1 | |
| Completed |
NCT00734656 -
Pharmacogenetics of Alcohol: Treatment Implications
|
N/A | |
| Completed |
NCT00402571 -
Hepatic Function During and Following Three Days of Acetaminophen Dosing in Alcoholics
|
Phase 4 | |
| Completed |
NCT00379093 -
Healthy Living as You Age
|
Phase 2 | |
| Completed |
NCT00802321 -
Pharmacokinetic Study of Single Dose Dutasteride in Healthy Subjects
|
N/A |